Nanotechnology has been considered for the improved delivery of various therapeutic agents, including drugs and genes. Indeed, liposomes and nanoparticles equipped with homing devices for the targeting of receptors over-expressed on the hepatic tissue have improved the treatment of various liver diseases.
In this review, various nanotechnology approaches employed for the treatment/imaging of liver disease, either in preclinical or in clinic are discussed.
2011-11-21
Eng.
Journal of Hepatology
Drug Delivery Technologies and Innovation, Pharmaceutical Sciences Department, Sanofi-aventis, 13 Quai Jules Guesde, 94403 Vitry-sur-Seine, France.
J Hepatol. 2011 Dec;55(6):1461-6
© Galenicom 1999-2013